Overview Financials News + Filings Key Docs Charts Ownership Insiders
All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
Tags
Director departure
Inv. presentation
Auditor change
|
|
iBio, Inc. (IBIO)
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 10/10/2023 |
8-K
| Credit agreement amendment |
| 10/05/2023 |
4
| Brenner Martin (See Remarks) has filed a Form 4 on iBio, Inc.|
Txns:
| Sold 5,267 shares
@ $0.3022, valued at
$1.6k
|
|
| 10/05/2023 |
EFFECT
| Form EFFECT - Notice of Effectiveness: |
| 10/03/2023 |
4
| Brenner Martin (See Remarks) has filed a Form 4 on iBio, Inc.|
Txns:
| Sold 4,215 shares
@ $0.311, valued at
$1.3k
|
|
| 10/02/2023 |
8-K
| Quarterly results |
| 09/29/2023 |
POS AM
| Form POS AM - Post-Effective amendments for registration statement: |
| 09/27/2023 |
8-K
| Quarterly results |
| 09/27/2023 |
10-K
| Annual Report for the period ended June 30, 2023 |
| 08/24/2023 |
4
| Duran Felipe (CFO) has filed a Form 4 on iBio, Inc.|
Txns:
| Granted 60,000 options to buy
@ $0.3459, valued at
$20.8k
|
|
| 08/24/2023 |
4
| Brenner Martin (See Remarks) has filed a Form 4 on iBio, Inc.|
Txns:
| Granted 120,000 options to buy
@ $0.3459, valued at
$41.5k
|
|
| 08/15/2023 |
D
| Form D - Notice of Exempt Offering of Securities: |
| 08/14/2023 |
424B3
| Form 424B3 - Prospectus [Rule 424(b)(3)]: |
| 08/14/2023 |
EFFECT
| Form EFFECT - Notice of Effectiveness: |
| 08/07/2023 |
8-K
| Entry into a Material Definitive Agreement, Results of Operations and Financial Condition, Material Modifications to Rights o... |
| 08/07/2023 |
424B5
| Form 424B5 - Prospectus [Rule 424(b)(5)]: |
| 08/04/2023 |
8-K
| Entry into a Material Definitive Agreement, Unregistered Sales of Equity Securities, Financial Statements and Exhibits ... |
| 07/28/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 07/13/2023 |
4
| Brenner Martin (See Remarks) has filed a Form 4 on iBio, Inc.|
Txns:
| Sold 47,020 shares
@ $0.5853, valued at
$27.5k
|
|
| 07/10/2023 |
8-K
| Quarterly results |
| 05/24/2023 |
4
| Brenner Martin (See Remarks) has filed a Form 4 on iBio, Inc.|
Txns:
| Sold 4,158 shares
@ $0.935, valued at
$3.9k
Sold 24 shares
@ $0.945, valued at
$22.7 |
|
| 05/19/2023 |
10-Q/A
| Quarterly Report for the period ended December 31, 2022 [amend] |
| 05/15/2023 |
10-Q
| Quarterly Report for the period ended March 31, 2023 |
| 04/24/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 04/24/2023 |
8-K
| Quarterly results |
| 04/03/2023 |
4
| Brenner Martin (See Remarks) has filed a Form 4 on iBio, Inc.|
Txns:
| Granted 50,000 shares
@ $0 |
|
| 04/03/2023 |
4
| Duran Felipe (CFO) has filed a Form 4 on iBio, Inc.|
Txns:
| Granted 37,500 shares
@ $0 |
|
| 04/03/2023 |
8-K
| Financial Statements and Exhibits Interactive Data |
| 03/28/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 03/13/2023 |
8-K
| Regulation FD Disclosure Interactive Data |
| 02/23/2023 |
4
| Brenner Martin (See Remarks) has filed a Form 4 on iBio, Inc.|
Txns:
| Sold 3,976 shares
@ $1.77, valued at
$7k
|
|
| 02/22/2023 |
424B3
| Form 424B3 - Prospectus [Rule 424(b)(3)]: |
| 02/14/2023 |
10-Q
| Quarterly Report for the period ended December 31, 2022 |
| 02/14/2023 |
3
| Form 3 - Initial statement of beneficial ownership of securities: |
| 02/09/2023 |
SC 13G
| VANGUARD GROUP INC reports a 5.3% stake in iBio Inc. |
|
|
|